An interventional study of PICC or subcutaneous venous port in Focus of Study, sponsored by Linkoeping University. Completed at 1 site in Sweden. Open to participants aged 18 Years to 120 Years. Per ClinicalTrials.gov, last updated 2018-01-30.
Sponsored by Linkoeping University · Not applicable, Interventional, and Supportive care
As of today there is very limited scientific knowledge in whicj of the two vascular access devices (PICC-line or venous ports) that offers the lowest complicationrates in cancerpatients. The study group wants to clearify this unsolved matter by comparing the two systems. Our primary endpoint is the presens of catheter related venous thrombosis. We are also looking at all catheter related complications and patient satisfaction.
Linkoeping University is the lead sponsor of 189 studies on the registry; 40 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
PICC line insertion.
Device: PICC or subcutaneous venous port
Subcutaneous venous port insertion
Device: PICC or subcutaneous venous port
The occurence of catheter related venous thrombosis
regular follow-ups at month 1, 3, 6 and 12.
Time frame: Upon clinical suspiscion during the one the patient i enrolled in the study
This study is completed, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Linkoeping University